Heros Health
Heros sells sermorelin and NAD+ by the month through a partner network it does not name. Its two sermorelin pages disagree on the price, and no product prints a dose.
Review by Leah Garner, clinical-evidence editor · Updated September 2026
The short version
Heros is a platform that says plainly it does not practice medicine, and it names four dispensing pharmacies. On the peptide side it names no clinician, prints no dose, and carries template copy that contradicts its own products. Sermorelin is priced at $449 on one page and $259 on another, both opening the same intake. Read the checkout carefully before you pay.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: NAD+ nasal spray, from $179/mo
All 50 states and Washington, D.C., per the FAQ
Visit Heros Health →Heros Health, Inc. is a cash-pay telehealth platform based in Katy, Texas, selling subscriptions across weight loss, sexual health, skin, hair, vitality and peptides. The peptide products that take an order are sermorelin, an NAD+ injection and an NAD+ nasal spray. PT-141 has a priced page, but the homepage marks it out of stock. BPC-157, CJC-1295 with ipamorelin and ipamorelin alone are also priced, while TB-500 and retatrutide are marked coming soon. Compounded semaglutide and tirzepatide sit on a separate weight-loss page.
What Heros Health prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)Price not published
- TirzepatideFDA-approved
- Injection (compounded)Price not published
Compounded semaglutide is $179 a month after a $129 first month, and tirzepatide $275 after $249. Semaglutide also has a quarterly plan at $435 and a six-month plan at $834. The page says the price is the same at every prescribed dose, and that there is no separate membership fee. No page states the form of either drug, so neither carries a price here.
Sexual health
- PT-141 (bremelanotide)FDA-approved
Listed by the seller; no price we hold.
PT-141 is priced at $189 a month on its own page, but the homepage's PT-141 section shows only an out-of-stock button. Its consultation link opens the NAD+ questionnaire. Until it can be ordered, it carries no price here.
Longevity
- NAD+Legal to compound
- Injection (compounded)From $249/mo
- Nasal spray (compounded)From $179/mo
NAD+ is sold as an injection at $249 a month and as a nasal spray at $179, each with a first-month saving of $75 and $54. Neither page states a vial size, a strength or a schedule, so there is no dose to compare. The shared FAQ calls NAD+ a peptide therapy, which it is not. It also tells nasal-spray buyers the product is typically given by subcutaneous injection, which is template text rather than guidance.
Recovery
- SermorelinLegal to compound
- Injection (compounded)From $449/mo
Sermorelin has two live product pages, $449 a month on the peptides hub and $259 on the vitality hub, and both open the same intake. Only the cheaper page says it is typically injected, and neither prints a dose or a vial size. The $449 page lists benefits copied from the weight-loss line, including appetite suppression. BPC-157, ipamorelin and the CJC-1295 blend are priced too, and none of the three is on a list that lets a pharmacy compound it.
Sleep
- SermorelinLegal to compound
- Injection (compounded)From $449/mo
The $259 sermorelin page claims improved sleep quality and recovery. No study is named beside the claim, and no dose or timing is printed.
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
Heros does not prescribe, and its medical disclaimer says so directly. It states that Heros Health does not practice medicine, and that care comes from independent licensed providers who use the platform. The weight-loss page adds that prescriptions are reviewed and signed by board-certified physicians in a partner clinical network. It names three of them: Dr. Amber Patel in family medicine, Dr. Scott Sanderson in emergency medicine and Dr. Scott Nass in family medicine. No medical group, license number or state is attached to any name. The peptide pages name no clinician at all, only a board-certified physician who reviews within 24 hours. Four pharmacies are named on a separate page: The Pharmacy Hub in Miami, Epiq Scripts in Texas, Dr. TelX in Washington and Emerald Compounding Pharmacy in Tampa. That page opens by saying prescriptions go through one trusted pharmacy partner, and never says which of the four fills a peptide order.
Every peptide page describes the same four steps. You complete an online assessment, a physician reviews it, the order ships free, and ongoing support follows as regular check-ins and prescription refills. No schedule is given for those check-ins. The intake runs on a separate Heros Health app, and the first screen asks about your goals. The weight-loss page promises built-in follow-ups for dose titration and side effects, without a cadence. The medical disclaimer lists a device with a camera and microphone as a requirement for consultations. No product page says a live visit will actually happen. The PT-141 page's consultation button opens the NAD+ intake rather than one of its own.
Are labs required?
Not mentioned
No peptide page mentions bloodwork, and none lists a lab charge. The medical disclaimer excludes conditions that need a physical exam or diagnostic testing. Whether a prescriber ever asks for labs before sermorelin is not stated.
Ready to start with Heros Health?
Lowest listed price: NAD+ nasal spray, from $179/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
The outcome claims are large and uncited. The vitality hub and homepage say NAD+ can increase cellular energy by up to 300%, with no source. The $449 sermorelin page promises clinically proven effectiveness and safety. Its benefits list then describes appetite suppression within 24 to 48 hours and weight loss averaging 15 to 20% of body weight. Those lines belong to a GLP-1 product, and they sit on a sermorelin page. The social proof does not agree with itself. Every product carries the same 4.9 out of 5 from 2,341 reviews, whatever the product. Member counts read over 250,000 on the vitality pages and over 500,000 on the peptides page. The homepage claims more than 1 million patients, and elsewhere 2.5 million treated. A 90-day guarantee badge sits on every peptide page with no terms beside it. The only wording appears on the erectile-dysfunction pages, which offer to refund your first order. The terms of service do not mention a guarantee.
| On Heros Health’s site | Source it gives |
|---|---|
| On Heros Health’s site“Increase cellular energy by up to 300%” | Source it givesNone given |
| On Heros Health’s site“Clinically proven effectiveness and safety (sermorelin)” | Source it givesNone given |
| On Heros Health’s site“Fast-acting appetite suppression within 24-48 hours (on the sermorelin page)” | Source it givesNone given |
| On Heros Health’s site“NAD+ levels decline by up to 50% by age 40” | Source it givesNone given |
| On Heros Health’s site“4.9/5 (2,341 reviews)” | Source it givesThe same figure appears on every product page |
| On Heros Health’s site“90-Day Guarantee” | Source it givesTerms appear only on the ED pages; the terms of service do not mention it |
Sold by Heros Health, not listed here
- BPC-157
- On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- CJC-1295
- On no FDA compounding list. The name does not appear in the 503A bulk drug substances categories (updated May 14, 2026) or in the 503B categories (updated March 21, 2025), so neither a 503A pharmacy nor a 503B outsourcing facility has a listed route to it.
- Ipamorelin
- "Ipamorelin Acetate" is in 503B Category 2, bulk drug substances that raise significant safety risks (list updated March 21, 2025). It is named on no 503A list, so neither an outsourcing facility nor a 503A pharmacy has a listed route to it.
- TB-500
- On no FDA compounding list: absent from the 503A categories (updated May 14, 2026) and the 503B categories (updated March 21, 2025). FDA's compounding advisory committee voted 8-6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- Retatrutide
- FDA states that retatrutide and cagrilintide "cannot be used in compounding under federal law", and that they "are not components of FDA-approved drugs and have not been found safe and effective for any condition". It is named on no 503A or 503B list.
- BPC-157
- On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- CJC-1295 with ipamorelin
- On no FDA compounding list. The name does not appear in the 503A bulk drug substances categories (updated May 14, 2026) or in the 503B categories (updated March 21, 2025), so neither a 503A pharmacy nor a 503B outsourcing facility has a listed route to it.
- Ipamorelin
- "Ipamorelin Acetate" is in 503B Category 2, bulk drug substances that raise significant safety risks (list updated March 21, 2025). It is named on no 503A list, so neither an outsourcing facility nor a 503A pharmacy has a listed route to it.
- TB-500
- On no FDA compounding list: absent from the 503A categories (updated May 14, 2026) and the 503B categories (updated March 21, 2025). FDA's compounding advisory committee voted 8-6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- Retatrutide
- FDA states that retatrutide and cagrilintide "cannot be used in compounding under federal law", and that they "are not components of FDA-approved drugs and have not been found safe and effective for any condition". It is named on no 503A or 503B list.
- PT-141
- The homepage marks it out of stock, and its product page's consultation button opens the NAD+ intake.
- Compounded semaglutide and tirzepatide
- Both are priced, but no page states whether they are injections or another form.
- MIC B12, erectile-dysfunction, hair and skin products
- A vitamin injection and medicines that are not peptides.
How it bills
Each peptide is a monthly subscription, printed as a price per month beside a limited-time saving on the first month. Subscriptions are charged in advance and renew automatically. You cancel in your Heros Health account, or by emailing the company's info address, at least 48 hours before renewal. The terms make dispensed compounded medication a final sale. Consultation fees become non-refundable once a provider has reviewed the intake, whether or not anything is prescribed. The $449 sermorelin page says the subscription includes the medication, the consultation, ongoing support and free shipping.
Availability: All 50 states and Washington, D.C., per the FAQ
LegitScript: seal displayed on the seller’s site
For and against
- For: Four dispensing pharmacies are named
- For: Plain statement that Heros does not prescribe
- For: Cancellation from your account, 48 hours ahead
- For: Shipping is free on every product
- Against: Two sermorelin prices for one product
- Against: No dose or vial size on any peptide
- Against: No clinician named on any peptide page
- Against: Template copy contradicts the products
- Against: Guarantee badge with no published terms
The evidence behind what it sells
- Tirzepatide Headache: What the Labels and Trial Results Recorded
- Vyleesi Drug Interactions: Birth Control, Naltrexone and Alcohol
- Does NAD Cause Cancer? What Human and Animal Studies Show
- Sermorelin vs HGH: A Signal to the Pituitary or the Hormone Itself
- Does Tirzepatide Make You Tired? What the Trials and Labels Show
- Peptides for Sex Drive: PT-141, Kisspeptin and Oxytocin in the Trials
Right for
A reader who already knows the sermorelin or NAD+ dose they want, and is ready to confirm the price and pharmacy at checkout.
Look elsewhere if
Anyone who wants to know who will prescribe, what dose they will get, or which sermorelin price applies before paying.
Other sellers for weight
50 Stars Health
Also prescribes Semaglutide, Tirzepatide.
Actin
Also prescribes Semaglutide, Tirzepatide.
AgelessRx
Also prescribes Semaglutide, Tirzepatide.
Heros Health
Frequently asked questions
- Who prescribes at Heros Health?
- Independent licensed providers who use the platform. The weight-loss page names three physicians in a partner clinical network, but no peptide page names anyone, and no medical group is given.
- Why are there two sermorelin prices?
- Two live pages sell Heros Sermorelin, at $449 and $259 a month, and both open the same intake. The site does not explain the difference, so confirm the figure at checkout.
- Which pharmacy fills the order?
- Heros names four: The Pharmacy Hub, Epiq Scripts, Dr. TelX and Emerald Compounding Pharmacy. It does not say which one fills a given peptide.
- What does the 90-day guarantee cover?
- On the peptide pages it is a badge with no terms. The erectile-dysfunction pages offer to refund a first order, and the terms of service say dispensed medication is a final sale.
See what Heros Health prescribes today
Heros Health sets its own prices, plans and the states it serves. Check them before you start.